Literature DB >> 12761121

Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals.

Chad S Brooks1, P Scott Hefty, Sarah E Jolliff, Darrin R Akins.   

Abstract

Lyme disease is a tick-borne infection that can lead to chronic, debilitating problems if not recognized or treated appropriately. Borrelia burgdorferi, the causative agent of Lyme disease, is maintained in nature by a complex enzootic cycle involving Ixodes ticks and mammalian hosts. Many previous studies support the notion that B. burgdorferi differentially expresses numerous genes and proteins to help it adapt to growth in the mammalian host. In this regard, several studies have utilized a dialysis membrane chamber (DMC) cultivation system to generate "mammalian host-adapted" spirochetes for the identification of genes selectively expressed during mammalian infection. Here, we have exploited the DMC cultivation system in conjunction with microarray technology to examine the global changes in gene expression that occur in the mammalian host. To identify genes regulated by only mammal-specific signals and not by temperature, borrelial microarrays were hybridized with cDNA generated either from organisms temperature shifted in vitro from 23 degrees C to 37 degrees C or from organisms cultivated by using the DMC model system. Statistical analyses of the combined data sets revealed that 125 genes were expressed at significantly different levels in the mammalian host, with almost equivalent numbers of genes being up- or down-regulated by B. burgdorferi within DMCs compared to those undergoing temperature shift. Interestingly, during DMC cultivation, the vast majority of genes identified on the plasmids were down-regulated (79%), while the differentially expressed chromosomal genes were almost entirely up-regulated (93%). Global analysis of the upstream promoter regions of differentially expressed genes revealed that several share a common motif that may be important in transcriptional regulation during mammalian infection. Among genes with known or putative functions, the cell envelope category, which includes outer membrane proteins, was found to contain the most differentially expressed genes. The combined findings have generated a subset of genes that can now be further characterized to help define their role or roles with regard to B. burgdorferi virulence and Lyme disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761121      PMCID: PMC155701          DOI: 10.1128/IAI.71.6.3371-3383.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Borrelia burgdorferi gene expression profiling with membrane-based arrays.

Authors:  Caroline Ojaimi; Chad Brooks; Darrin Akins; Sherwood Casjens; Patricia Rosa; Abdallah Elias; Alan Barbour; Algis Jasinskas; Jorge Benach; Laura Katonah; Justin Radolf; Melissa Caimano; Jon Skare; Kristen Swingle; Simon Sims; Ira Schwartz
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 2.  Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe.

Authors:  R S Lane; J Piesman; W Burgdorfer
Journal:  Annu Rev Entomol       Date:  1991       Impact factor: 19.686

3.  Characterization of a candidate Borrelia burgdorferi beta3-chain integrin ligand identified using a phage display library.

Authors:  J Coburn; W Chege; L Magoun; S C Bodary; J M Leong
Journal:  Mol Microbiol       Date:  1999-12       Impact factor: 3.501

4.  Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family.

Authors:  X Yang; T G Popova; K E Hagman; S K Wikel; G B Schoeler; M J Caimano; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Porin activity of the native and recombinant outer membrane protein Oms28 of Borrelia burgdorferi.

Authors:  J T Skare; C I Champion; T A Mirzabekov; E S Shang; D R Blanco; H Erdjument-Bromage; P Tempst; B L Kagan; J N Miller; M A Lovett
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.

Authors:  D S Samuels; R T Marconi; W M Huang; C F Garon
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

7.  Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi.

Authors:  V G Bundoc; A G Barbour
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

8.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Colony formation and morphology in Borrelia burgdorferi.

Authors:  T J Kurtti; U G Munderloh; R C Johnson; G G Ahlstrand
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.

Authors:  C I Champion; D R Blanco; J T Skare; D A Haake; M Giladi; D Foley; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  158 in total

1.  Analysis of a Borrelia burgdorferi phosphodiesterase demonstrates a role for cyclic-di-guanosine monophosphate in motility and virulence.

Authors:  Syed Z Sultan; Joshua E Pitzer; Michael R Miller; Md A Motaleb
Journal:  Mol Microbiol       Date:  2010-04-27       Impact factor: 3.501

2.  CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi.

Authors:  S L Rajasekhar Karna; Eva Sanjuan; Maria D Esteve-Gassent; Christine L Miller; Mahulena Maruskova; J Seshu
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Borrelia burgdorferi sigma54 is required for mammalian infection and vector transmission but not for tick colonization.

Authors:  Mark A Fisher; Dorothee Grimm; Amy K Henion; Abdallah F Elias; Philip E Stewart; Patricia A Rosa; Frank C Gherardini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

4.  Regulation of expression of the fibronectin-binding protein BBK32 in Borrelia burgdorferi.

Authors:  Ming He; Bethany K Boardman; Dalai Yan; X Frank Yang
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

5.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease.

Authors:  Mahulena Maruskova; M Dolores Esteve-Gassent; Valerie L Sexton; J Seshu
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 7.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Differential expression of a putative CarD-like transcriptional regulator, LtpA, in Borrelia burgdorferi.

Authors:  X Frank Yang; Martin S Goldberg; Ming He; Haijun Xu; Jon S Blevins; Michael V Norgard
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

9.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  The BosR regulatory protein of Borrelia burgdorferi interfaces with the RpoS regulatory pathway and modulates both the oxidative stress response and pathogenic properties of the Lyme disease spirochete.

Authors:  Jenny A Hyde; Dana K Shaw; Roger Smith Iii; Jerome P Trzeciakowski; Jon T Skare
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.